Determinants of initiation and suboptimal use of anti-ulcer medication: A study of the Quebec older population

Journal of the American Geriatrics Society

Volumn 45, Issue 7, 1997, Pages 853-856

  Moride, Yola ^a,c   Melnychuk, David ^a   Monette, Johanne ^b   Abenhaim, Lucien ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIULCER AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE;

ARTICLE; CONTROLLED STUDY; DRUG INDICATION; DRUG UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; PEPTIC ULCER; PRESCRIPTION;

EID: 0030793992     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb01514.x     Document Type: Article

References (23)

1. Tamblyn RM, McLeod PJ, Abrahamowicz M et al. Questionable prescribing for the elderly patients in Quebec. Can Med Assoc J 1994;150:1801-1809.
2. Schmader K, Hanlon JT, Weinberger M et al. Appropriateness of medication prescribing in ambulatory patients. J Am Geriatr Soc 1994;42:1241-1247.
3. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA 1994;272:292-296.
4. Ferguson JA. Patient age as a factor in drug prescribing practices. Can J Aging 1990;9:278-295.
5. Shorr RI, Bauwens SF, Landefeld CS. Failure to limit quantities of benzodiazepine hypnotic drugs for outpatients: Placing the elderly at risk. Am J Med 1990;89:725-732.
6. Chrischilles EA, Helling DK, Booth BM et al. Documentation and appropriateness of prescribing for Veterans Administration ambulatory-care patients. Am J Hosp Pharm 1988;45:2345-2351.
7. Ray WA, Federspiel CF, Schaffner W. A study of antipsychotic drug use in nursing homes: Epidemi-ological evidence suggestions misuse. Am J Public Health 1980;70:485-491.
8. Keith M, Cason DM, Helling DK. Antiulcer prescribing program in a state correctional system. Ann Pharmacother 1994;28:72-76.
9. Thors H, Sigurdsson H, Oddsson E, Thjodleifsson B. Survey of prescriptions for peptic ulcer drugs (ATC class AOB2) in Iceland. Scand J Gastroenterol 1994;29:988-994.
10. 2-receptor antagonists in the long-term-care setting. J Am Geriatr Soc 1992;40:359-364.
11. Régie de l'assurance-maladie du Québec. Annual Statistics 1991. Québec: Services de l'évaluation des programmes et des statistiques, Services des Communications, Bibliothèque Nationale du Québec, 1992.
12. Drug, Facts and Comparisons. St.Louis, MO, 1991:1767-1787.
13. Maton PN. Omeprazole. N Engl J Med. 1991;324:965-975.
14. Need we poison the elderly so often (editorial)? Lancet 1988;2:20-22.
15. Freston JM. Omeprazole, hypergatrinemia, and gastric carcinoid tumors. Ann Intern Med 1994;121:232-233.
16. Koop H. Omeprazole long-term therapy: How great is the risk of developing a carcinoid tumor? Z Gastroenterol 1988;26:769-771.
17. Reddrop CJ. Gastric polyposis: Onset during long-term therapy with omeprazole. Med J Aust 1993;158:144.
18. 2-receptor antagonists: Standard therapy for acid-peptic disease. N Engl J Med 1990;323:1672-1680.
19. Singh G, Rosen Ramey D, Morfeld D et al. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. Arch Intern Med 1996;156:1530-1536.
20. Griffin MR, Piper JM, Daugherty JR et al. Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Ann Intern Med 1991;1:257-263.
21. Soil AH, Weinstein WM, Kurata J, McCarthy D. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 1991;114:307-319.
22. Fries JF, Miller SR, Spitz PW et al. Toward an epidemiology of gastropathy associated with nonsteroidal anti-inflammatory drug use. Gastroenterology 1989;96:647-655.
23. Amstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987;28:527-532.